Time will tell, but I don't believe it will be the
Post# of 153887
https://www.proactiveinvestors.com/companies/...23141.html
Quote:
Slightly disagree. Any other revenue generating firm, yes. This is a pre-revenue biotech. It WOULD be considered material. JMO.

